Independent medication information written for everyday readers.
The Medication Guide Library

Author: The Medication Guide Editorial Team

Advertisement
Comparisons

Tesamorelin vs. Sermorelin: Approval, Uses, and Evidence

Both relate to growth-hormone-releasing pathways, but they differ in regulatory history, studied uses, and product status. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.

Growth-Hormone Pathway

Tesamorelin: FDA-Approved Use, Evidence, and Common Misunderstandings

Tesamorelin is an FDA-approved prescription medicine for a specific indication involving excess abdominal fat in adults with HIV and lipodystrophy. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.

Comparisons

Topical GHK-Cu vs. Injectable GHK-Cu: Why Route Matters

A topical cosmetic and an injectable product have different absorption, sterility, dosing, and safety considerations. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.

Comparisons

TB-500 vs. BPC-157: What the Evidence Can—and Cannot—Tell Us

TB-500 and BPC-157 are frequently grouped as recovery peptides, although they are distinct compounds with different proposed mechanisms. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.

Peptides

TB-500 Explained: Thymosin Beta-4, Research, and Regulatory Status

TB-500 is marketed in connection with thymosin beta-4 biology, but commercial naming and studied molecules should not be assumed identical. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.

Peptides

BPC-157 Safety: Unknowns, Product Quality, and Red Flags

The absence of large controlled trials leaves important questions about dose, interactions, long-term effects, and vulnerable populations. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.

Peptides

BPC-157 for Tendons and Ligaments: Evidence vs. Online Claims

Tendon and ligament claims often rely on preclinical models rather than robust clinical trials in injured people. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.